In this study, we examined the eect of the stable expression of Smad7 in two dierent cell lines on apoptosis induced by various stimuli including TGF-b, serum withdrawal, loss of cell adhesion (anoikis) and TNF-a. Smad7 increased TGF-b-mediated apoptosis in Mv1Lu cells as well as anoikis and/or serum withdrawalinduced apoptosis in Mv1Lu and MDCK cells. Smad7 markedly decreased the activity of the survival NF-kB transcription factor in MDCK cells. Interestingly, the stable expression of oncogenic Ras in MDCK cells which suppressed Smad7 inhibition of NF-kB also suppressed Smad7 potentiation of serum withdrawal-induced apoptosis and anoikis. In addition, Smad7 inhibited TNF-a stimulation of NF-kB and increased TNF-a-mediated apoptosis in MDCK cells. Our results provide the ®rst evidence that Smad7 induces sensitization of cells to dierent forms of cell death. They moreover demonstrate that Smad7 inhibits the survival NF-kB factor, providing a potential mechanism whereby Smad7 potentiates cell death. Oncogene (2001) 20, 879 ± 884.
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Apoptosis, or programmed cell death, is a physiological process essential to normal development and homeostasis of multicellular organisms. Apoptosis is promoted by various extracellular stimuli including transforming growth factor b (TGF-b). TGF-b is a cytokine that elicits a broad spectrum of cellular responses through type I and type II receptors and downstream eectors designated as Smads. TGF-b induces the phosphorylation of Smad2 and/or Smad3 which oligomerize with Smad4 and translocate to the nucleus to regulate gene transcription (Derynck et al., 1998 , ten Dijke et al., 2000 . The Smad family also comprises Smad6 and Smad7, two proteins identi®ed as inhibitory Smads since they prevent TGF-bmediated responses. Smad7 is the product of an early gene induced by TGF-b through the Smad pathway (Nakao et al., 1997 , Nagarajan et al., 1999 . Smad7 expression is also induced by interferon-g (IFN-g) through the Jak/STAT pathway (Ulloa et al., 1999) and by TNF-a through activation of the nuclear factor kB (NF-kB) (Bitzer et al., 2000) , raising the interesting possibility that Smad7 may be involved in additional signaling pathways.
In the past few months, the role of Smad7 in TGF-b signaling revealed to be more complex than it was originally suspected. Indeed, a few recent papers pointed to the ability of Smad7 to enhance or even to mediate some TGF-b eects. Thus, although Smad7 inhibited apoptosis induced by TGF-b in B cells (Patil et al., 2000) , M1 and Hep3B cells (Yamamura et al., 2000) , it was recently identi®ed as an eector of TGF-b to promote apoptosis in prostatic and keratinocyte cell lines (LandsroÈ m et al., 2000) . In view of these observations, we sought to gain further insight into the role of Smad7 in cell death, and we investigated the eect of the stable expression of Smad7 in dierent cell lines on apoptosis induced by various stimuli including TGF-b, TNF-a, serum withdrawal, and loss of cell adhesion.
We ®rst examined the eect of Smad7 overexpression on TGF-b-mediated apoptosis using a previously de®ned cell system in which the level of Smad7 expression is controlled by the human inducible metallothionein IIA promoter (Itoh et al., 1998) . Mv1Lu cells stably transfected with a pMEP4 (Mv1Lu-pMEP4 cells) or a pMEP4-Smad7 (Mv1Lu-S7 cells) expression vector were treated with the inducer ZnCl2 and with or without TGF-b before being examined for apoptosis by the DNA fragmentation assay and¯ow cytometry analysis. Mv1Lu-S7 cells, which displayed a high level of Smad7 expression (Itoh et al., 1998) , exhibited increased DNA degradation ( Figure 1a ) and a 2.3-fold higher percentage of apoptotic cells as compared to controls (Figure 1b) . Thus Smad7 increased TGF-b-mediated apoptosis in Mv1Lu cells, consistent with recent results in dierent cell lines (LandstroÈ m et al., 2000) .
In the course of the experiments, we observed that Mv1Lu-S7 cells cultured in 10% FCS medium containing ZnCl2 proliferated normally and did not exhibit any morphological feature of apoptosis, whereas when they were cultured in 0.5% FCS medium plus ZnCl2, they exhibited massive cell death as compared to controls. We therefore examined the eect of Smad7 on serum withdrawal-induced apoptosis and found that Mv1Lu-S7 maintained for 48 h in serum-free medium containing 100 mM ZnCl2 exhibited a marked increase in both DNA degradation and the percentage of apoptotic cells (Figure 1c ). To gain further insight into the role of Smad7 in serum withdrawal-induced apoptosis, MDCK cells, which are epithelial cells previously used in apoptosis and anoikis assays (Khwaja et al., 1997) were stably transfected with a pcDNA3-Flag-Smad7 expression vector. MDCK cells selected for Smad7 overexpression (MDCK-S7 cells, clones 6, 8) are presented in Figure 2a . Noteworthy, MDCK-S7 cells, like Mv1Lu-S7 cells, proliferated normally in 10% FCS medium and did not undergo apoptosis (data not shown). However, the percentage of apoptotic cells measured in MDCK-S7 cells (clone 8) maintained for 48 h in serum-free medium was signi®cantly increased as compared to controls ( Figure  2b ), which agrees with the aforementioned observation in Mv1Lu-S7 cells ( Figure 1c ). Of interest, the Smad7-mediated increase in serum withdrawal-induced apoptosis appears not to be restricted to epithelial cells since the stable expression of Smad7 also potentiated this process in CHO-R15 cells, a ®broblastic cell line that we repeatedly used in recent studies (Bertrand et al., 1998 , Desbois-Mouthon et al., 2000 .
Next, MDCK and MDCK-S7 cells were compared for their ability to undergo apoptosis upon removal from the extracellular matrix (anoikis). As shown in Figure 2c , MDCK-S7 cells (clones 6, 8) held for 12 h in suspension exhibited a 2 ± 3-fold increase in the percentage of apoptotic cells as compared to MDCK cells, indicating that the former were more sensitive to anoikis than the latter. Accordingly, this process started earlier in MDCK-S7 cells than in MDCK cells (Figure 2d) .
The above results provide the ®rst evidence that Smad7 sensitizes dierent cell lines to apoptosis induced by stimuli distinct from TGF-b such as serum withdrawal and loss of cell adhesion. An interesting possibility is that Smad7 could inhibit the activity of survival signaling molecules targeted by most factors regulating apoptosis. Good candidates include Akt/ PKB and NF-kB, two signaling molecules which play a critical role in the inhibition of apoptosis induced by various stimuli in most cell types (Downward, 1998 , Van Antwerp et al., 1998 . To examine the eect of Smad7 on Akt activity, cell lysates from MDCK and MDCK-S7 cells (clones 6, 8) were immunoblotted with an antibody directed against phospho-Akt, i.e. the active form of Akt. As shown in Figure 3a , the levels Dijke, de®ned in the text) were successively cultured as follows: 12 h in 10% FCS medium with ZnCl2 (100 mM), 12 h in 0.5% FCS medium with ZnCl2, and 12 h in 10% FCS medium with or without TGF-b (10 ng/ml). Cell lysates (600 mg of protein) were submitted to the DNA fragmentation assay as described (Bertrand et al., 1998) . (b) Mv1Lu-pMEP4 and Mv1Lu-S7 cells treated as in (a) were submitted to¯ow cytometry analysis as described (Mazars et al., 2000) . (c) Mv1Lu and Mv1Lu-S7 cells maintained in serum-free or 10% FCS medium for 48 h were examined for apoptosis by the DNA fragmentation assay and¯ow cytometry analysis of propidium iodide-stained cells (percentages of apoptotic cells reported Then, 8) were transiently transfected with a NF-kB and a bgalactosidase reporter plasmids and were compared for NF-kB activity. As shown in Figure 3b , MDCK-S7 cells exhibited a twofold decrease in NF-kB activity as compared to control cells. Moreover, MDCK cells transiently transfected with increasing amounts of Smad7 cDNA in the presence of the above reporter plasmids exhibited a dose-dependent inhibition of NFkB activity (Figure 3b ). We also tested for this inhibitory eect in CHO-R15 cells and found a similar repression of NF-kB activity by Smad7 (data not shown). Together, these results suggest that Smad7 expression leads to the sensitization of MDCK cells to apoptosis through NF-kB inhibition.
To evaluate this hypothesis, we took advantage of the ability of oncogenic Ras to constitutively activate NF-kB (Mayo et al., 1997) and investigated the eect of this activation on both Smad7 inhibition of NF-kB and Smad7 potentiation of anoikis and serum withdrawal-induced apoptosis in MDCK cells. To this end, MDCK cells overexpressing Ras. Val 12 (MDCK-ras cells) were stably transfected with a Smad7 expression vector. Two clones overexpressing Smad7 (MDCK-ras-S7, clones 1, 2) were examined for NF-kB activity and sensitivity to anoikis and serum withdrawal-induced apoptosis in comparison to MDCK, MDCK-ras and MDCK-S7 cells (Figure 4a ). MDCK-ras cells exhibited a constitutive increase in NF-kB activity as compared to MDCK cells (Figure 4a ). More importantly, the inhibition of NF-kB activity by Smad7 found in MDCK cells (Figures 3b and 4a) was not observed in MDCK-ras cells (Figure 4a ), indicating that Ras. Val 12 suppressed this inhibition. Interestingly, Ras. Val 12 also suppressed the ability of Smad7 to potentiate anoikis in MDCK cells, as supported by the ®nding that the percentages of apoptotic cells determined in MDCK-ras and MDCK-ras-S7 cells held in suspension for 24 h were identical (2 ± 4%) despite the fact that the percentage of apoptotic cells measured in MDCK-S7 cells (69%) was about twofold higher than that determined in MDCK cells (37%) (Figure 4b ). This indicates that Ras. Val 12 protected MDCK cells against anoikis irrespective of the absence (Khwaja et al., 1997, this study) or presence (this study) of Smad7. Essentially similar results were obtained when examin- ing serum withdrawal-induced apoptosis in these cells (data not shown). These results, together with the data showing the ability of Ras. Val 12 to suppress the inhibitory eect of Smad7 on NF-kB activity are consistent with the hypothesis that the inhibition of the survival NF-kB transcription factor may be one of the mechanisms whereby Smad7 potentiates cell death.
To provide further evidence for this hypothesis, we examined the eect of Smad7 on TNF-a-mediated apoptosis. TNF-a is a cytokine known to counteract its own apoptotic eect through the activation of the survival factor NF-kB (Van Antwerp et al., 1998) . This is supported by the ®nding that the inhibition of NFkB activity produced by a dominant-negative form of Ik Ba increased TNF-a-mediated apoptosis (Liu et al., 1996) . Therefore we reasoned that Smad7 inhibition of NF-kB should also increase TNF-a-mediated apoptosis, and we examined the eect of Smad7 on both TNF-a stimulation of NF-kB and TNF-a-mediated apoptosis. MDCK and MDCK-S7 cells (clones 6, 8) incubated with or without TNF-a were submitted to electromobility shift and DNA degradation assays. In MDCK and MDCK-S7 cells, basal NF-kB DNAbinding activity was detected as a single complex containing the inactive NF-kB p50/p50 homodimer, as determined by supershift analysis with a speci®c antip50 antibody (Figure 4c) . In MDCK cells, TNF-a increased the intensity of this complex and induced the appearance of an upper complex containing the active NF-kB p65/p50 heterodimer. In MDCK-S7 cells, TNFa had a far lower eect than in MDCK cells, indicating that Smad7 inhibited TNF-a stimulation of NF-kB DNA-binding activity (Figure 4c ). Similarly, a marked decrease (55+6%, n=3) in TNF-a-stimulated NF-kB transcriptional activity was found in MDCK-S7 cells. More importantly, the ladders of DNA degradation observed in TNF-a-treated MDCK-S7 cells (clones 6, 8) were more pronounced than in TNF-a-treated MDCK cells (Figure 4d ), pointing to increased TNFa-mediated apoptosis as a result of the ability of Smad7 to inhibit NF-kB activity in MDCK cells.
In summary, the present study provides the ®rst evidence that Smad7 induces sensitization of the cells to dierent forms of cell death. This ®nding contrasts with the ability of Smad7 to repress TGF-b-mediated growth arrest in MDCK cells and to act as an oncogene in pancreatic cells by suppressing TGF-b-mediated inhibition of cell growth (Klee et al., 1999) . However, one possibility could be that Smad7 produces each of these eects in function of the cell context, as is the case for ras, c-myc and E2F-1 which also display apoptotic and oncogenic properties (Mayo et al., 1997 , Weinberg, 1997 , Phillips et al., 1999 . This interpretation is consistent with the notion that cells with deregulated expression of transforming proteins initiate a suicide program to escape neoplastic transformation. In this regard, we previously reported that the tumorigenic progression of Caco-2 cells induced by the ras and polyoma middle T oncogenes was associated with both a dramatic decrease in the activity of NF-kB and a loss of cell adhesion to the extracellular matrix (Cadoret et al., 1997) . In addition, (left) MDCK and MDCK-S7 cells were transfected with a (Igk3)-conaluc and a bgal-control reporter plasmids (0.05 mg/well) as described (Bertrand et al., 1998) . Cells were then examined for normalized luciferase activity (ratio of NF-kB-mediated luciferase activity to the b galactosidase activity measured in each extract). (Right) MDCK cells transfected with the above reporter plasmids together with increasing amounts (0.02, 0.03, 0.04 mg) of a Smad7 expression plasmid were analysed for luciferase activity. Results are representative of two experiments (a) or the means+s.e.mean of three experiments (b) our study demonstrates that Smad7 inhibits NF-kB activity, providing a potential mechanism whereby Smad7 potentiates dierent forms of cell death. Smad7 was recently shown to be the product of a NF-kB responsive gene induced by TNF-a and CD4O (Bitzer et al., 2000 , Patil et al., 2000 . Therefore, the Smad7-dependent inhibition of NF-kB might re¯ect a negative feedback control exerted by Smad7 on NF-kB activity. At present, the molecular mechanisms whereby Smad7 inhibits NF-kB are unknown. Recently, Lopez-Rovira et al. (2000) reported that Smad3 cooperated with NFkB to activate gene expression in response to TGF-b signaling. Since Smad7 can act as an inhibitor of Smad3 (ten Dijke et al., 2000) , one attractive possibility is that Smad7 might inhibit NF-kB by interfering with Smad3. Further studies will be required to address this issue. (Cadoret et al., 1997) ] and MDCK-ras-S7 cells (MDCK-ras cells stably transfected with pcDNA3-FLAG-Smad7) were examined for Smad7 expression and then for NF-kB activity as in Figure 3. (b) MDCK, MDCK-S7, MDCK-ras and MDCK-ras-S7 cells held in suspension for 24 h were analysed by¯ow cytometry. (c) Nuclear extracts from MDCK and MDCK-S7 cells incubated for 30 min in 10% FCS medium with or without TNF-a were analysed for NF-kB DNA binding activity by EMSA as described (Cadoret et al., 1997) . The NF-kB DNA complexes were identi®ed by supershift analysis with speci®c antibodies against the p50 and p65 subunits of NF-kB (data not shown). 
